Keywords
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to Sleep Medicine ClinicsAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- Cognitive behavioral therapy, singly and combined with medication, for persistent insomnia: a randomized controlled trial.JAMA. 2009; 301: 2005-2015
- Chronic insomnia.Am J Psychiatry. 2008; 165: 678-686
- Midlife insomnia and subsequent mortality: the Hordaland health study.BMC public health. 2014; 14: 1-10
- The associations of insomnia with costly workplace accidents and errors: results from the America Insomnia Survey.Arch Gen Psychiatry. 2012; 69: 1054-1063
- Insomnia symptoms and risk for unintentional fatal injuries—the HUNT study.Sleep. 2014; 37: 1777-1786
- The epidemiology of insomnia: associations with physical and mental health.: the HUNT-2 study.J psychosomatic Res. 2009; 67: 109-116
- The treatments of chronic insomnia: a review of benzodiazepine receptor agonists and psychological and behavioral therapies.Sleep Med Rev. 2009; 13: 205-214
- Insomnia with objective short sleep duration and incident hypertension: the Penn State Cohort.Hypertension. 2012; 60: 929-935
- Insomnia with objective short sleep duration: the most biologically severe phenotype of the disorder.Sleep Med Rev. 2013; 17: 241-254
- Clinical practice guideline for the pharmacologic treatment of chronic insomnia in adults: an American Academy of Sleep Medicine clinical practice guideline.J Clin Sleep Med. 2017; 13: 307-349
- Clinical guideline for the evaluation and management of chronic insomnia in adults.J Clin Sleep Med. 2008; 4: 487-504
- Behavioral and psychological treatments for chronic insomnia disorder in adults: an American Academy of Sleep Medicine clinical practice guideline.J Clin Sleep Med. 2021; 17: 255-262
- The Insomnia Severity Index: psychometric indicators to detect insomnia cases and evaluate treatment response.Sleep. 2011; 34: 601-608
- Comparison of sleep condition and sleep-related psychological activity after cognitive-behavior and pharmacological therapy for chronic insomnia.Psychother Psychosom. 2006; 75: 220-228
- Cognitive behavioral therapies for insomnia and hypnotic medications: considerations and controversies.Sleep Med Clin. 2019; 14: 253-265
- Association of eszopiclone, zaleplon, or zolpidem with complex sleep behaviors resulting in serious injuries, including death.Pharmacoepidemiol Drug Saf. 2020; 29: 684-691
- Insomnia, hypnotic use, and road collisions: a population-based, 5-year cohort study.Sleep. 2020; 43: zsaa032
- A systematic review and network meta-analysis of randomized controlled trials evaluating the evidence base of melatonin, light exposure, exercise, and complementary and alternative medicine for patients with insomnia disorder.J Clin Med. 2020; 9: 1949
- Insomnia and hypnotic use, recorded in the minimum data set, as predictors of falls and hip fractures in Michigan nursing homes.J Am Geriatr Soc. 2005; 53: 955-962
- Behavioral and pharmacological therapies for late-life insomnia: a randomized controlled trial.JAMA. 1999; 281: 991-999
- Sleep restriction therapy for insomnia is associated with reduced objective total sleep time, increased daytime somnolence, and objectively impaired vigilance: implications for the clinical management of insomnia disorder.Sleep. 2014; 37: 229-237
- No pain, no gain: an exploratory within-subjects mixed-methods evaluation of the patient experience of sleep restriction therapy (SRT) for insomnia.Sleep Med. 2011; 12: 735-747
- Acceptability, tolerability, and potential efficacy of cognitive behavioural therapy for insomnia disorder subtypes defined by polysomnography: a retrospective cohort study.Scientific Rep. 2018; 8: 1-6
- The clinical effects of sleep restriction therapy for insomnia: a meta-analysis of randomised controlled trials.Sleep Med Rev. 2021; 58: 101493
- Who is at risk for dropout from group cognitive-behavior therapy for insomnia?.J psychosomatic Res. 2008; 64: 419-425
- Incidence, persistence, and remission rates of insomnia over 5 years.JAMA Netw open. 2020; 3: e2018782
- Long-term outcome after discontinuation of benzodiazepines for insomnia: a survival analysis of relapse.Behav Res Ther. 2005; 43: 1-14
- Combined therapeutics for insomnia: should our first approach be behavioral or pharmacological?.Sleep Med. 2006; 7 ([published Online First: Epub Date]|): S15-S19
- CBT-I in the short sleep duration phenotype.Adapting Cognitive Behavioral Therapy for Insomnia: Elsevier, United Kingdom2022: 369-401
- Cognitive behavioural treatment for insomnia in primary care: a systematic review of sleep outcomes.Br J Gen Pract. 2019; 69: e657-e664
- The efficacy of cognitive and behavior therapies for insomnia on daytime symptoms: a systematic review and network meta-analysis.Clin Psychol Rev. 2020; 80: 101873
- Daytime functioning in older patients suffering from chronic insomnia: treatment outcome in a randomized controlled trial comparing CBT with zopiclone.Behav Res Ther. 2008; 46: 623-641
- Eszopiclone co-administered with fluoxetine in patients with insomnia coexisting with major depressive disorder.Biol Psychiatry. 2006; 59: 1052-1060
- A double-blind randomized controlled trial of augmentation and switch strategies for refractory social anxiety disorder.Am J Psychiatry. 2014; 171: 44-53
- Eszopiclone for the treatment of posttraumatic stress disorder and associated insomnia: a randomized, double-blind, placebo-controlled trial.J Clin Psychiatry. 2011; 72: 6681
- Effects of cognitive behavioral therapy for insomnia on suicidal ideation in veterans.Sleep. 2015; 38: 259-265
- Effectiveness of an online insomnia program (SHUTi) for prevention of depressive episodes (the GoodNight Study): a randomised controlled trial.Lancet Psychiatry. 2016; 3: 333-341
- Insomnia as a predictor of depression: a meta-analytic evaluation of longitudinal epidemiological studies.J Affective Disord. 2011; 135: 10-19
- Cognitive behavioural therapy monotherapy for insomnia: a meta-analysis of randomized controlled trials.Asian J Psychiatry. 2020; 49: 101828
- Effects of opioid, hypnotic and sedating medications on sleep-disordered breathing in adults with obstructive sleep apnoea.Cochrane Database Syst Rev. 2015; 7: 1-57
- Efficacy of cognitive-behavioral therapy for insomnia combined with antidepressant pharmacotherapy in patients with comorbid depression and insomnia: a randomized controlled trial.J Clin Psychiatry. 2016; 77: 2446
- Cognitive behavioral therapy for insomnia comorbid with psychiatric and medical conditions: a meta-analysis.JAMA Intern Med. 2015; 175: 1461-1472
- Prevention of incident and recurrent major depression in older adults with insomnia: a randomized clinical trial.JAMA Psychiatry. 2022; 79: 33-41
- Cognitive-behavioral therapy for insomnia in older adults.Cogn Behav Pract. 2021; 29: 146-160
- CBT-I in patients who wish to reduce use of hypnotic medication.Adapting Cognitive Behavioral Therapy for Insomnia: Elsevier, United Kingdom2022: 437-456
- Psychosocial intervention for discontinuing benzodiazepine hypnotics in patients with chronic insomnia: a systematic review and meta-analysis.Sleep Med Rev. 2019; 48: 101214
- Randomized clinical trial of supervised tapering and cognitive behavior therapy to facilitate benzodiazepine discontinuation in older adults with chronic insomnia.Am J Psychiatry. 2004; 161: 332-342
- Adapting cognitive behavioral therapy for insomnia.Elsevier, United Kingdom2021
- Transcranial magnetic stimulation therapeutic applications on sleep and insomnia: a review.Sleep Sci Pract. 2021; 5: 1-10
- Hypnosis intervention effects on sleep outcomes: a systematic review.J Clin Sleep Med. 2018; 14: 271-283
- Treating comorbid insomnia in older adults via cognitive-behavioural treatment, bright light and exercise.Health. 2014; 2014: 960-968
- Searching for perfect sleep: the continuing evolution of GABAA receptor modulators as hypnotics.J Psychopharmacol. 2010; 24: 1601-1612
- Zolpidem and gender: are women really at risk?.J Clin Psychopharmacol. 2019; 39: 189-199
- Insomnia pharmacotherapies: pharmacodynamics, strategies, new directions, and key measures in clinical trials.Handbook Behav Neurosci. 2019; 30: 639-648
- Effectiveness of non-benzodiazepine hypnotics in treatment of adult insomnia: meta-analysis of data submitted to the Food and Drug Administration.BMJ. 2012; 345: 1-13
- Long-term, non-nightly administration of zolpidem in the treatment of patients with primary insomnia.J Clin Psychiatry. 2004; 65: 10719
- Nonmedical use of benzodiazepines and Z-drugs in the UK.Br J Clin Pharmacol. 2021; 87: 1676-1683
- The epidemiology of benzodiazepine misuse: a systematic review.Drug and alcohol dependence. 2019; 200: 95-114
- Stahl's essential psychopharmacology: neuroscientific basis and practical applications.Cambridge university press, 2021
- Twelve months of nightly zolpidem does not lead to rebound insomnia or withdrawal symptoms: a prospective placebo-controlled study.J Psychopharmacol. 2012; 26: 1088-1095
- Residual symptoms after natural remission of insomnia: associations with relapse over 4 years.Sleep. 2019; 42: zsz122
- Impaired driving performance associated with effect of time duration in patients with primary insomnia.Sleep. 2014; 37: 1565-1573
- Insomnia and accidents: cross-sectional study (EQUINOX) on sleep-related home, work and car accidents in 5293 subjects with insomnia from 10 countries.J Sleep Res. 2014; 23: 143-152
- Role of sleep disturbances in occupational accidents among women.Scand J Work Environ Health. 2015; 41: 368-376
- Insomnia and cognitive performance: a systematic review and meta-analysis.Sleep Med Rev. 2019; 48: 101205
- Quantitative measures of nocturnal insomnia symptoms predict greater deficits across multiple daytime impairment domains.Behav Sleep Med. 2015; 13: 73-87
- A greater extent of insomnia symptoms and physician-recommended sleep medication use predict fall risk in community-dwelling older adults.Sleep. 2017; 40: zsx142
- An exploratory analysis of the association of circadian rhythm dysregulation and insomnia with suicidal ideation over the course of treatment in individuals with depression, insomnia, and suicidal ideation.J Clin Sleep Med. 2020; 16: 1311-1319
- How much sleep do you need? A comprehensive review of fatigue related impairment and the capacity to work or drive safely.Accid Anal Prev. 2021; 151: 105955
- Associations between insomnia, sleep duration and poor work ability.J psychosomatic Res. 2015; 78: 45-51
- Nightly treatment of primary insomnia with eszopiclone for six months: effect on sleep, quality of life, and work limitations.Sleep. 2007; 30: 959-968
- Hyperarousal in insomnia and hypnotic dose escalation.Sleep Med. 2016; 23: 16-20
- Polypharmacy: evaluating risks and deprescribing.Am Fam Physician. 2019; 100: 32-38
- Benzodiazepines I: upping the care on downers: the evidence of risks, benefits and alternatives.J Clin Med. 2018; 7: 17
- Absence of definitive scientific evidence that benzodiazepines could hinder the efficacy of exposure-based interventions in adults with anxiety or posttraumatic stress disorders: a systematic review of randomized clinical trials.Depress Anxiety. 2020; 37: 1231-1242
- How does cognitive behavioural therapy for insomnia work? A systematic review and meta-analysis of mediators of change.Clin Psychol Rev. 2021; 86: 102027
- Who to refer to a behavioral insomnia clinic?—recommendations based on treatment rationale and response prediction.Curr Sleep Med Rep. 2021; 7: 1-8
- Adherence to cognitive behavioral therapy for insomnia (CBTI) among women following primary breast cancer treatment: a pilot study.Behav Sleep Med. 2012; 10: 217-229
- Why treat insomnia?.J Prim Care Community Health. 2021; 12 (21501327211014084)
- Comparative meta-analysis of pharmacotherapy and behavior therapy for persistent insomnia.Am J Psychiatry. 2002; 159: 5-11
- Effects of trazodone versus cognitive behavioral therapy in the insomnia with short sleep duration phenotype: a preliminary study.J Clin Sleep Med. 2020; 16: 2009-2019
- Insomnia patients with objective short sleep duration have a blunted response to cognitive behavioral therapy for insomnia.Sleep. 2017; 40: zsw012
- Impact of phenotypic heterogeneity of insomnia on the patients’ response to cognitive-behavioral therapy for insomnia: current perspectives.Nat Sci Sleep. 2019; 11: 367
- The evolving nexus of sleep and depression.Am J Psychiatry. 2021; 178: 896-902
- Reducing suicidal ideation through insomnia treatment (REST-IT): a randomized clinical trial.Am J Psychiatry. 2019; 176: 957-965
- Cognitive behavioral therapy for insomnia with veterans: evaluation of effectiveness and correlates of treatment outcomes.Behav Res Ther. 2014; 53: 41-46
- Cognitive behavioral therapy to support sleep for psychiatric patients with insomnia.ProqQuest, Ann Arbour, MI2020
- Focusing on insomnia symptoms to better understand depression: a STAR∗ D report.J affective Disord. 2020; 260: 183-186
- Sleep, insomnia, and depression.Neuropsychopharmacology. 2020; 45: 74-89
- Sleep restriction therapy. Behavioral treatments for sleep disorders.Elsevier, 2011: 9-19
- Impact of sleep restriction on affective functioning in adolescents with attention-deficit/hyperactivity disorder.J Child Psychol Psychiatry. 2020; 61: 1160-1168
- Sleep disturbances and risk of falls in older community-dwelling men: the outcomes of Sleep Disorders in Older Men (MrOS Sleep) Study.J Am Geriatr Soc. 2014; 62: 299-305
- Actigraphy-measured sleep characteristics and risk of falls in older women.Arch Intern Med. 2008; 168: 1768-1775
- Self-reported sleep and nap habits and risk of falls and fractures in older women: the study of osteoporotic fractures.J Am Geriatr Soc. 2006; 54: 1177-1183
- Direct structural insights into GABAA receptor pharmacology.Trends Biochem Sci. 2021; 46: 502-517
- Sharpening our understanding of the consequences of insomnia: the relationship between insomnia and everyday cognitive failures.Cogn Ther Res. 2012; 36: 134-139
- Improvement of idiopathic central sleep apnea with zolpidem.J Clin Sleep Med. 2009; 5: 122-129
- Impaired central control of sleep depth propensity as a common mechanism for excessive overnight wake time: implications for sleep apnea, insomnia and beyond.J Clin Sleep Med. 2020; 16: 341-343
- The effect of non-benzodiazepine sedative hypnotics on CPAP adherence in patients with OSA: a systematic review and meta-analysis.Sleep. 2021; 44: zsab077
- Association between benzodiazepine receptor agonists and snoring among women in the nurses’ health study.JAMA Otolaryngology–Head Neck Surg. 2017; 143: 162-167
- Approaches to the assessment of adherence to CBT-I, predictors of adherence, and the association of adherence to outcomes: a systematic review.Sleep Med Rev. 2022; 63: 101620
- Brain mechanisms of insomnia: new perspectives on causes and consequences.Physiol Rev. 2021; 101: 995-1046
- Cognitive behavior therapy and pharmacotherapy for insomnia: a randomized controlled trial and direct comparison.Arch Intern Med. 2004; 164: 1888-1896
- Sequential combinations of drug and cognitive behavioral therapy for chronic insomnia: an exploratory study.Behav Res Ther. 2005; 43: 1611-1630
- Long-term maintenance of therapeutic gains associated with cognitive-behavioral therapy for insomnia delivered alone or combined with zolpidem.Sleep. 2017; 40https://doi.org/10.1093/sleep/zsx002
- Speed and trajectory of changes of insomnia symptoms during acute treatment with cognitive–behavioral therapy, singly and combined with medication.Sleep Med. 2014; 15: 701-707
- Effectiveness of sequential psychological and medication therapies for insomnia disorder: a randomized clinical trial.JAMA psychiatry. 2020; 77: 1107-1115
- Association between insomnia patients’ pre-treatment characteristics and their responses to distinctive treatment sequences.Sleep. 2022; 45: zsab245
- Insomnia treatment response as a function of objectively measured sleep duration.Sleep Med. 2019; 56: 135-144
- Long-term, non-nightly administration of zolpidem in the treatment of patients with primary insomnia.J Clin Psychiatry. 2004; 65: 1128-1137
- Hyperarousal and beyond: new insights to the pathophysiology of insomnia disorder through functional neuroimaging studies.Brain Sci. 2017; 7: 23
- Effect of 1 month of zopiclone on obstructive sleep apnoea severity and symptoms: a randomised controlled trial.Eur Respir J. 2018; 52: 1-12
- Concomitant benzodiazepine and opioids decrease sleep apnoea risk in chronic pain patients.ERJ Open Res. 2020; 6: 1-10
- Hyperarousal and sleep reactivity in insomnia: current insights.Nat Sci Sleep. 2018; 10: 193
- Prevalence and predictors of prescription sleep aid use among individuals with DSM-5 insomnia: the role of hyperarousal.Sleep. 2016; 39: 825-832
- Impaired central control of sleep depth propensity as a common mechanism for excessive overnight wake time: implications for sleep apnea, insomnia and beyond.J Clin Sleep Med. 2020; 16: 341-343
- Effect of cognitive behavioural therapy for insomnia on sleep architecture and sleep EEG power spectra in psychophysiological insomnia.J Sleep Res. 2004; 13: 385-393
- Chronic hypnotic use at 10 years—does the brand matter?.Eur J Clin Pharmacol. 2018; 74: 1623-1631
- The effects of modafinil and cognitive behavior therapy on sleep continuity in patients with primary insomnia.Sleep. 2004; 27: 715-725
- Effect of treatment preference in randomized controlled trials: systematic review of the literature and meta-analysis.Patient. 2019; 12: 593-609
- Use of actigraphy for the evaluation of sleep disorders and circadian rhythm sleep-wake disorders: an American Academy of Sleep Medicine clinical practice guideline.J Clin Sleep Med. 2018; 14: 1231-1237
Article info
Identification
Copyright
© 2022 Elsevier Inc. All rights reserved.
